Skip to main content
Premium Trial:

Request an Annual Quote

Jay Short, Alisa Judge, Andre Hoekema, Shawn Cain

Jay Short, chairman and CEO of Diversa, will retire from the board of directors of Invitrogen within the next six months, the company said in a recent SEC filing.

Alisa Judge was named vice president of human resources for San Diego-based Claritas. Previously, she was vice president for human resources at Chemtronics. Before that, she was director of global staffing and retention at Invitrogen.

Andre Hoekema joins Galapagos as managing director of Galadeno, Galapagos' services unit. Previously, Hoekema was Invitrogen's managing director for corporate development in Europe and before that, held the same position for Molecular Probes.

Shawn Cain was named vice president for manufacturing operations, effective April 25, for Los Angeles-based Arbios Systems, a medical device company. Cain joins Arbios from Becton Dickinson, where he was responsible for two biologics manufacturing facilities. Cain previously worked with WR Grace & Co.'s research division and its wholly owned subsidiary, Circe Biomedical, where he was involved in development of HepatAssist, the artificial liver currently being developed by Arbios. Arbios said that concurrent with Cain's appointment, it has entered into a multi-year lease with American Integrated Biologics on a biosecure facility in Woodstock, Conn., which will be used to manufacture pig liver cells to be used in an Arbios project.


The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.